Financial results - CRISFARMALINE SRL

Financial Summary - Crisfarmaline Srl
Unique identification code: 25210423
Registration number: J02/229/2009
Nace: 4773
Sales - Ron
880.227
Net Profit - Ron
56.700
Employees
4
Open Account
Company Crisfarmaline Srl with Fiscal Code 25210423 recorded a turnover of 2024 of 880.227, with a net profit of 56.700 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Crisfarmaline Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 65.261 293.328 419.526 558.089 524.155 637.795 640.044 746.566 843.084 880.227
Total Income - EUR 65.261 293.331 419.743 558.093 524.159 637.797 640.891 746.730 843.121 880.285
Total Expenses - EUR 58.699 247.074 365.907 491.426 465.727 550.050 567.229 657.375 770.529 814.848
Gross Profit/Loss - EUR 6.562 46.258 53.836 66.667 58.431 87.747 73.662 89.355 72.592 65.438
Net Profit/Loss - EUR 4.517 40.098 48.991 60.915 53.561 82.564 68.459 83.298 65.220 56.700
Employees 2 3 4 5 5 5 5 5 5 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 5.0%, from 843.084 euro in the year 2023, to 880.227 euro in 2024. The Net Profit decreased by -8.156 euro, from 65.220 euro in 2023, to 56.700 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Crisfarmaline Srl

Rating financiar

Financial Rating -
CRISFARMALINE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Crisfarmaline Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Crisfarmaline Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Crisfarmaline Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Crisfarmaline Srl - CUI 25210423

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 24.246 19.846 30.091 25.184 27.780 30.290 31.877 30.938 28.984 24.019
Current Assets 35.208 80.216 111.307 125.691 123.745 163.676 159.710 149.545 160.267 181.852
Inventories 24.600 39.142 59.155 46.182 47.502 52.782 51.958 72.199 72.406 76.588
Receivables 7.248 8.107 28.167 42.196 32.832 46.508 52.239 66.832 73.341 84.970
Cash 3.360 32.967 23.985 37.313 43.410 64.385 55.513 10.514 14.520 20.294
Shareholders Funds 4.562 40.151 88.463 109.059 113.348 135.159 68.508 83.346 65.583 56.748
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 54.933 59.937 53.187 42.848 38.860 59.518 123.984 98.090 125.014 150.791
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 181.852 euro in 2024 which includes Inventories of 76.588 euro, Receivables of 84.970 euro and cash availability of 20.294 euro.
The company's Equity was valued at 56.748 euro, while total Liabilities amounted to 150.791 euro. Equity decreased by -8.469 euro, from 65.583 euro in 2023, to 56.748 in 2024.

Risk Reports Prices

Reviews - Crisfarmaline Srl

Comments - Crisfarmaline Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.